PRIMARY STUDY
Inhibitory Effects of β-Caryophyllene on Helicobacter pylori Infection: A Randomized Double-blind, Placebo-controlled Study
Key Findings: The β-caryophyllene group showed significant improvement in nausea and epigastric pain, as well as a decrease in the serum IL-1β levels. β-caryophyllene improves dyspepsia symptoms and can be considered a useful supplementary treatment for gastrointestinal disease.
Type of Study: Double Blind Clinical Trial
Study Sample Size: 66
Study Result: Positive
Research Location(s): South Korea
Year of Pub: 2019
Cannabinoids Studied:
Phytocannabinoid Source: Not Applicable
Terpenes Studied: ß-Caryophyllene
Dosage: β-caryophyllene (126 mg/day)
Route of Administration: Oral (Ingestion)
Citation: Shim HI, et al. [Inhibitory Effects of β-caryophyllene on Helicobacter pylori Infection: A Randomized Double-blind, Placebo-controlled Study]. Korean J Gastroenterol. 2019; 74:199-204. doi: 10.4166/kjg.2019.74.4.199
Authors: Shim HI, Song DJ, Shin CM, Yoon H, Park YS, Kim N, Lee DH
